Keyphrases
Prognostic Factors
100%
Prostate Cancer Patients
100%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
100%
Regional Lymph Node Metastasis
100%
Castration-resistant Prostate Cancer
45%
Free Time
27%
Progression-free
27%
Multivariate Analysis
18%
Chemotherapy
18%
Logistic Regression
18%
Bone Metastasis
18%
Cancer-specific Survival
18%
Malignant Cells
9%
Metastasis
9%
Prostate Cancer
9%
Lymph Node
9%
Lymph Node Metastasis
9%
Tumor Biology
9%
Chemotherapy Response
9%
Initial Diagnosis
9%
Genetic Studies
9%
Prognostic Significance
9%
Molecular Study
9%
Response to Chemotherapy
9%
Prognostic Effect
9%
Cox Proportional Hazards Regression Model
9%
Cox Proportional Hazards Regression
9%
Proportional Analysis
9%
Prostate-specific Antigen Response
9%
Advanced Prostate Cancer
9%
Hormonal Therapy
9%
Nonregional
9%
Medicine and Dentistry
Lymph Node Metastasis
100%
Prognostic Factor
100%
Prostate Cancer
100%
Castration Resistant Prostate Cancer
41%
Chemotherapy
33%
Progression Free Survival
25%
Multivariate Analysis
16%
Logistic Regression Analysis
16%
Proportional Hazards Model
16%
Bone Metastasis
16%
Cancer Specific Survival
16%
Metastatic Carcinoma
8%
Lymph Node
8%
Hormone Therapy
8%
Prostate Specific Antigen
8%
Tumor Biology
8%
Antigen Response
8%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Lymph Node Metastasis
100%
Castration Resistant Prostate Cancer
41%
Chemotherapy
33%
Progression Free Survival
25%
Bone Metastasis
16%
Cancer Specific Survival
16%
Neoplasm
8%
Prostate Specific Antigen
8%
Hormone Cancer Therapy
8%